Competitor benchmarking and performance gap analysis for a leading European medical device player

  • Identified opportunities for expansion and plausible revenue streams

  • Identified potential geographies and activation levers from competitors


CLIENT CHALLENGES
  • A leading European medical device player wanted to evaluate its competitive positioning relative to other major players’
  • Key challenges were :
    • Expanding its geographical footprint and product portfolio
    • Developing a roadmap for launching products in new and emerging-market segments
    • Identifying potential activation levers and competitors’ strategies
    • Identifying plausible challenges during expansion
OUR APPROACH
  • Benchmarking competitors based on :
    • Operating segments
    • Geographical footprint – manufacturing and sales
    • Products and pipeline
    • Peer analysis and scoring
    • Collaboration and partnerships
    • Impact of competitors
  • Industry profiling based on :
    • Market size, industry growth
    • Trends, drivers and challenges
    • Country policies
    • M&A target screening
    • Regulatory research
IMPACT DELIVERED
  • Evaluated the company’s relative position in each therapeutic area and overall
  • Helped the company understand key opportunity areas and activation levers to unlock value
Thank you for sharing your details

Your file will start downloading automatically

If it does not download within 1 minute,

Share this on

What we have done

Product launch strategy for European biopharmaceutical company
What we are proud of

>50%

savings in staffing costs

25%

increase in outreach

Opportunity assessment and market attractiveness for one of the top 10 pharmaceutical major
What we are proud of

>50%

savings in staffing costs

25%

increase in outreach

Assessing viability of entering the NSCLC market
What we are proud of

>50%

savings in staffing costs

25%

increase in outreach

Assessment of GCC pharmaceutical market for a global European pharma major
What we are proud of

>50%

savings in staffing costs

25%

increase in outreach

Supplier assessment and industry benchmarking for a global top 10 pharmaceutical company
What we are proud of

>50%

savings in staffing costs

25%

increase in outreach

Research on a multiple sclerosis drug with help from global neurologists
What we are proud of

>50%

savings in staffing costs

25%

increase in outreach

Procurement in non-Food FMCG Industry
What we are proud of

>50%

savings in staffing costs

25%

increase in outreach